Analyst Ratings for Cellectar Biosciences (CLRB)
CLRB Rating Summary
CLRB Price Target Summary
- Highest: $11.00 (Roth/MKM)
- Lowest: $10.00 (Maxim Group)
- Average: $10.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.33 (+270.4%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$10.33 (+270.4%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | Ladenburg Thalmann | Kevin DeGeeter | New Coverage | Buy (N/A) |
10.00 (N/A) |
3.20 (2.79) |
-12.81% | Details |
| 3/10/2026 | Maxim Group | Jason McCarthy | Upgrade | Buy (Hold) |
10.00 (N/A) |
2.75 (2.79) |
1.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
